Continuous Glucose Monitors: Best Data To Date, But Youths Pose Challenge
This article was originally published in The Gray Sheet
Executive Summary
Continuous glucose monitor manufacturers expect research reported out of Rome last week will boost the still-nascent market for the products and help make the case for better reimbursement
You may also be interested in...
Continuous Monitoring-Pump Combo Wins Out In Medtronic Diabetes Study
Continuous glucose monitoring and treatment with Medtronic's MiniMed Paradigm REAL-Time insulin pump shows clear-cut advantages over daily insulin injections in treating adult and pediatric type-1 diabetes patients, according to study results reported June 29
Continuous Monitoring-Pump Combo Wins Out In Medtronic Diabetes Study
Continuous glucose monitoring and treatment with Medtronic's MiniMed Paradigm REAL-Time insulin pump shows clear-cut advantages over daily insulin injections in treating adult and pediatric type-1 diabetes patients, according to study results reported June 29
American Diabetes Association Meeting In Brief
Diabetes diagnosis: A1C assays, which provide results reflecting average glucose levels over a 2-3 month period, should be the new standard test for making an initial diagnosis of diabetes, an international committee of experts recommended June 5 at the American Diabetes Association annual scientific sessions in New Orleans. A1C is a standard tool for monitoring and managing treatment for diabetes, but diagnosis is typically achieved with a fasting plasma glucose test, or, in some cases, an oral glucose tolerance test. The committee, assembled by ADA, the International Diabetes Federation and the European Association for the Study of Diabetes, noted that A1C values vary less than the other tests and that A1C assays have technical and ease-of-use benefits. An A1C value of 6.5% or greater should generally be used for diagnosis, though it cannot be viewed as an absolute dividing line, the committee said. The three organizations have yet to officially endorse the recommendation. Bio-Rad, MEC Dynamics, Bayer and Roche are among dozens of A1C test kit manufacturers